KromaTiD adds Surefire Medical founder to board

LONGMONT — Biotechnology firm KromaTiD Inc. has added James Chomas, medical device firm Surefire Medical Inc.’s founder, to its board of directors. 

Chomas joins KromaTiD as the firm aims to accelerate commercialization of its genomic structural services.

“KromaTiD has developed an important and innovative advancement in understanding the integrity of the genome, which has broad applications in supporting CRISPR therapy development, uncovering genetic causes of undiagnosed diseases, and cancer diagnostics,” Chomas said in a prepared statement. “I’m honored to join the board and to partner with the KromaTiD team to drive commercial success in this exciting period of gene editing advancement.”

SPONSORED CONTENT

Commercial Solar is a big investment, but not an overwhelming one

Solar offers a significant economic benefit for commercial property owners while also positively impacting the environment and offering a path to compliance for new municipal requirements like Energize Denver. A local, experienced solar installer will help you navigate the complexities of commercial solar to achieve financial success for your project.

© 2021 BizWest Media LLC